melatonin has been researched along with Myasthenia Gravis in 2 studies
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin may trigger exacerbations of myasthenia gravis, probably due to an upregulation of the adaptive immune system and an interaction with the corticosteroids and other immunosuppressant treatments." | 7.96 | Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre. ( Casasnovas, C; Nedkova-Hristova, V; Vélez-Santamaría, V, 2020) |
| "Melatonin may trigger exacerbations of myasthenia gravis, probably due to an upregulation of the adaptive immune system and an interaction with the corticosteroids and other immunosuppressant treatments." | 3.96 | Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre. ( Casasnovas, C; Nedkova-Hristova, V; Vélez-Santamaría, V, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, T | 1 |
| Niu, C | 1 |
| Sun, C | 1 |
| Ma, Y | 1 |
| Guo, R | 1 |
| Ruan, Z | 1 |
| Gao, Y | 1 |
| Lu, X | 1 |
| Li, H | 1 |
| Lin, Y | 1 |
| Lin, J | 1 |
| Li, Z | 1 |
| Nedkova-Hristova, V | 1 |
| Vélez-Santamaría, V | 1 |
| Casasnovas, C | 1 |
2 other studies available for melatonin and Myasthenia Gravis
| Article | Year |
|---|---|
Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis.
Topics: Adult; Aged; Female; Forkhead Transcription Factors; Humans; Interleukin-10; Male; Melatonin; Middle | 2020 |
Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre.
Topics: Adrenal Cortex Hormones; Adult; Aged, 80 and over; Female; Humans; Immunoglobulins, Intravenous; Mal | 2020 |